Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1372644 | Bioorganic & Medicinal Chemistry Letters | 2009 | 4 Pages |
Abstract
A novel series of c-jun N-terminal kinase (JNK) inhibitors were designed and developed from a high-throughput-screening hit. Through the optimization of the piperazine amide 1, several potent compounds were discovered. The X-ray crystal structure of 4g showed a unique binding mode different from other well known JNK3 inhibitors.
Graphical abstractA novel series of c-jun N-terminal kinase (JNK) inhibitors were designed and developed from high-throughput-screening lead 1.Figure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Youseung Shin, Weiming Chen, Jeff Habel, Derek Duckett, Yuan Yuan Ling, Marcel Koenig, Yuanjun He, Tomas Vojkovsky, Philip LoGrasso, Theodore M. Kamenecka,